Straumann Holding AG (STMNN) Stock Price & Analysis
STMNN Stock Chart & Stats
- Day’s Range
- MXN 2,105.85 - MXN 2,105.85
- 52-Week Range
- MXN 2,105.85 - MXN 2,577.02
- Previous Close
- MXN 2,105.85
- Volume
- N/A
- Average Volume (3M)
- 0
- Market Cap
- MXN 354.19B
- Enterprise Value
- MXN 17.11B
- Total Cash (Recent Filing)
- MXN 380.99M
- Total Debt (Recent Filing)
- MXN 510.94M
- Price to Earnings (P/E)
- 41.8
- Beta
- -0.04
- Next Earnings
- Feb 24, 2027 (Est.)
- EPS Estimate
- 38.72
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 1.37%
Bulls Say, Bears Say
Bulls Say
Global Growth And Market-share Gains
Broad organic growth and reported market-share gains indicate that Straumann is expanding its customer base and strengthening its competitive position. Momentum across regions and product franchises supports durable revenue growth beyond any single market or product cycle over the next several quarters.
Strong Implantology Position And Innovation Pipeline
Leadership in core implantology, combined with digital, orthodontic and workflow innovation, gives Straumann several avenues to deepen customer relationships and capture adjacent demand. The pipeline can support future growth while reinforcing differentiation through integrated clinical solutions.
Reaffirmed Growth And Margin Outlook
The reaffirmed outlook signals management confidence in continued demand, disciplined cost control and manufacturing efficiency. Expected revenue acceleration alongside margin expansion would improve earnings quality and strengthen the company’s ability to fund innovation and commercial expansion.
Bears Say
Profitability Softened Despite Revenue Growth
Lower operating and net margins despite higher revenue show that recent growth has not translated fully into earnings. If cost, investment or product-mix pressure persists, profitability could remain below prior levels and reduce the operating leverage expected from continued expansion.
China VBP Creates Structural Pricing Risk
China’s procurement process could reset prices across part of Straumann’s portfolio and intensify competition from local manufacturers. Even with volume growth, lower realized prices could pressure regional revenue quality and margins, making the company’s China strategy more dependent on mix and execution.
Cash Conversion And Free Cash Flow Weakened
Positive cash generation remains a strength, but declining free cash flow and a persistent gap versus accounting profit indicate weaker conversion than earnings alone suggest. Continued deterioration could constrain internally funded investment and make capital allocation less flexible during expansion.
Straumann Holding AG News
STMNN FAQ
What was Straumann Holding AG’s price range in the past 12 months?
What is Straumann Holding AG’s market cap?
When is Straumann Holding AG’s upcoming earnings report date?
How were Straumann Holding AG’s earnings last quarter?
Is Straumann Holding AG overvalued?
Does Straumann Holding AG pay dividends?
What is Straumann Holding AG’s EPS estimate?
How many shares outstanding does Straumann Holding AG have?
What happened to Straumann Holding AG’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Straumann Holding AG?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Straumann Holding AG
Straumann Holding AG is a global leader in providing advanced solutions for tooth replacement and orthodontic treatment. The company actively researches, develops, manufactures, and distributes a comprehensive range of dental products and services designed for tooth correction, restoration, replacement, and the prevention of tooth loss. Its extensive portfolio includes various dental implant systems (such as titanium, titanium alloy, ceramic, and mini implants), specialized surgical instruments, sophisticated CAD/CAM prosthetics, and the Clear Correct orthodontic aligners. Straumann also supplies vital biomaterials, including bone substitutes, membranes, and biologics, alongside cutting-edge digital tools like intraoral scanners, 3D printers, and milling machines for dental professionals and laboratories. Additionally, the company offers educational and training services to its customers. Straumann serves a diverse clientele, encompassing general dentists, specialists, dental technicians, laboratories, and institutional clients such as distributors, hospitals, and universities, reaching approximately 100 countries through its broad network of subsidiaries and partners. Established in 1954, Straumann Holding AG is headquartered in Basel, Switzerland.
- Sector
- General
- Industry
- Medical - Instruments & Supplies
- CEO
- Guillaume Daniellot
- Employees
- 11,582
- Website
- www.straumann.com
- Address
- Peter Merian-Weg 12, Basel, BS, 4002, CH
Straumann Holding AG (STMNN) Earnings & Revenues
STMNN Earnings Call
Earnings Call SentimentPositive
The call was strongly positive overall. Straumann reported accelerating organic growth, broad regional momentum, expanding digital and scanner adoption, progress in ClearCorrect, a growing innovation pipeline and reaffirmed revenue and margin guidance. The main challenges were Brazil's temporary demand weakness, uncertainty and potential pricing pressure from China's VBP 2.0, currency effects and cautious North American consumer conditions, but management expressed confidence in its strategy, execution and midterm targets.
View all MX:STMNN earnings summariesSTMNN Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 4 | 1 | 13 |
| Technical Analysis | 3 | 1 | 2 |
| Moving Averages | 1 | 0 | 11 |




